Nymox Pharmaceutical Corporation Gains 44.81%
Mon, Dec 05, 2022 at 07:03 PM
Nymox Pharmaceutical Corporation (NYMX:NASDAQ) jumped higher at $0.41, a gain of 44.8%. On Mon, Dec 05, 2022, NYMX:NASDAQ hit a New 2-Week High of $0.41. From Mon, Nov 21, 2022, the stock recorded 11.11% Up Days and 30.00% Green Days
The stock spiked on Mon, Dec 05, 2022 at $0.53 with a volume of 4M+.
About Nymox Pharmaceutical Corporation (NYMX:NASDAQ)
Nymox Pharmaceutical Corp, along with its subsidiaries, is a biopharmaceutical corporation, engaged in research and development of diagnostics and drugs for brain disorders and diseases of the aged with an emphasis on Alzheimer's disease.
Top 10 Gainers:
- Winc Inc. (WBEV:NYSEMKT), 100.1%
- Mmtec, Inc. (MTC:NASDAQ), 50%
- Nymox Pharmaceutical Corporation (NYMX:NASDAQ), 44.81%
- China Pharma Holdings, Inc. (CPHI:NYSEMKT), 44.38%
- Digital Brands Group Inc. (DBGI:NASDAQ), 37.33%
- SatixFy Communications Ltd. (SATX:NYSEMKT), 34.88%
- EHang Holdings Limited (EH:NASDAQ), 34.27%
- Vivani Medical Inc. Com (VANI:NASDAQ), 31.18%
- Anebulo Pharmaceuticals Inc. (ANEB:NASDAQ), 27.92%
- Titan Medical Inc. (TMDI:NASDAQ), 27.82%